Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma

• Asıl Yazarlar: Jain MD (Yazar), Bachmeier CA (Yazar), Phuoc VH (Yazar), Chavez JC (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Dove Medical Press, 2018-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Michael D Jain,1,2 Christina A Bachmeier,3 Vania H Phuoc,2 Julio C Chavez,2,4 1Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA; 2Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA; 3Department of Pharmacy, Mo...